Evidence for the involvement of the benzodiazepine receptor complex in hepatic encephalopathy. Implications for treatment with benzodiazepine receptor antagonists.
Basile
A S
AS
Section on Neurobiology, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland 20892.
Gammal
S H
SH
D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D001569:Benzodiazepines; D006501:Hepatic Encephalopathy / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D011963:Receptors, GABA-A / Q000502:physiology*
D014151:Anti-Anxiety Agents; D011963:Receptors, GABA-A; D001569:Benzodiazepines